Delivery Order SPE2DB22D2006-SPE2DB25FW3GJ
- Not listed
- The Defense Logistics Agency awarded a $149,190 delivery order to AmerisourceBergen Drug Corporation for 500 boxes containing 10 mg tablets of benazepril hydrochloride. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with delivery required by June 21, 2023. The firm-fixed-price order was...
- The Defense Logistics Agency awarded a $39,480 delivery order to Amerisourcebergen Drug Corporation for 100 boxes of 20mg Benazepril HCl tablets. The firm fixed price order is being fulfilled under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DOD medical treatment facilities. Performance will take place in Conshohocken, Pennsylvania from August 18-21, 2023. No subcontractors or set aside designations were specified. The order supports DLA's...
- This federal contract award, identified as SPE2DB22D3004|SPE2DB25FPR61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,797.16 firm fixed-price delivery order is for the supply of Benazepril Hydrochloride 5 mg tablets, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25,...
- The Defense Logistics Agency awarded a $43,860 delivery order to AmerisourceBergen Drug Corporation for 500 boxes containing 40mg Benazepril HCl tablets. The order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. AmerisourceBergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by September 19, 2023. The firm fixed price contract has a period of performance of one day...
- The Defense Logistics Agency awarded a $20,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561326619 Benazepril HCL 20 MG Tablet 100s. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by June 26, 2023 in support of the Defense Logistics Agency's logistics and procurement programs. No major subcontractors or set aside designations were identified...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,651.83, is for the supply of 4,563,587,051 units of Benazepril HCL 40 mg tablets. The contract has a completion date of February 8, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal...
- The Defense Logistics Agency awarded a $8,430 delivery order to Amerisourcebergen Drug Corporation for 100 tablets of Benazepril-HCTZ 20-25 mg. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by August 14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for hypertension medication supports the Defense Logistics Agency's mission to provide critical logistics support to the military services....
- The Defense Logistics Agency (DLA) awarded a $1,334.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Benicar 40 mg tablets (30-count units) on May 30, 2025, with completion targeted for June 2, 2025. This non-set-aside award was competitively procured and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,250.15 to AmerisourceBergen Drug Corp for the supply of Benicar 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 19, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $2,069.16 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of AMLOD-VALSA-HCTZ 5-160-25 MG in 30-count packaging. The contract, which is non-set-aside and competitively awarded on a firm fixed price basis, is scheduled for completion by August 5, 2025, with performance to occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3GJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Benazepril-HCL 20-25 mg tablets (100 count) with a ceiling value of $2,493.95. This is a firm fixed-price, non-set-aside contract awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This award is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. As one of the Defense Logistics Agency's primary pharmaceutical vendors, AmerisourceBergen Drug Corp serves critical medical supply chain functions for military and veteran healthcare systems, delivering a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's competitively awarded contract portfolio demonstrates its capability to fulfill diverse federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/8/25 |